Adnan Alexander Kassier, MD. FACC. FSCAI (@akassier) 's Twitter Profile
Adnan Alexander Kassier, MD. FACC. FSCAI

@akassier

Interventional & Structural Cardiologist @UMHealthSparrow. Alumni @Corewellhealth @ABH_IC_Fellows. Tweets are my own.

ID: 932767970195070976

calendar_today21-11-2017 00:29:48

1,1K Tweet

1,1K Followers

1,1K Following

Adnan Alexander Kassier, MD. FACC. FSCAI (@akassier) 's Twitter Profile Photo

Congratulations team! We transitioned our center to a single operator watchman for a few months now using #ICE. We do single operator TEE in difficult ICE cases. It's time to move structural heart forward and decrease reliance on imaging specialists. SCAI Andrew M. Goldsweig, MD, MS

Dr Shariq Shamim (@shariqshamimmd) 's Twitter Profile Photo

Even though ABIM has a complete monopoly and most hospitals have not yet accepted NBPAS, I signed up. Strength is in numbers, sign up today and do your part. #CardioTwitter

Benoy Shah MD (@dr_benoy_n_shah) 's Twitter Profile Photo

Deep dive on #EARLYTAVR from ##TCT2024 Lots already said & discussed It takes time to read the paper, read the supplementary appendix, analyse the results, think about them etc! Some thoughts...🧵

Deep dive on #EARLYTAVR from ##TCT2024

Lots already said & discussed

It takes time to read the paper, read the supplementary appendix, analyse the results, think about them etc!

Some thoughts...🧵
Natalie Marrero (@n_marreromed) 's Twitter Profile Photo

Looking for a statin alternative? If statins aren’t enough to hit your patient's lipid goals, we’ve got you covered! 🌟Check out our latest infographic on non-statin lipid-lowering therapies.📊Discover their efficacy, outcomes, and pros and cons. #Lipids #Prevention #CardioNerds

Looking for a statin alternative? If statins aren’t enough to hit your patient's lipid goals, we’ve got you covered! 🌟Check out our latest infographic on non-statin lipid-lowering therapies.📊Discover their efficacy, outcomes, and pros and cons. #Lipids #Prevention #CardioNerds
Neerav Sheth MD MBA FACC FSCAI FSCCT (@neeravshethmd) 's Twitter Profile Photo

Dear Colleagues, I am asking you to take 3 minutes in the next day to send a message to Congress to eliminate the proposed 2.8% cut to Medicare reimbursement, which will take effect on January 1, 2025. lnkd.in/eBntX5BM Sincerely, Neerav Sheth, MD, FACC Pa Chapter ACC

Adnan Alexander Kassier, MD. FACC. FSCAI (@akassier) 's Twitter Profile Photo

Excited to share my outcomes CRT Meeting on 4D ICE-guided LAAC Siemens Healthineers BostonSci Cardiology. 72 consecutive all comers pt: 🔹️Procedure is safe and feasible 🔹️97% successful LAAC 🔹️97% cessation of AC @ 45 days 🔹️All dc ~ 24 hrs 🔹️Average procedure time 47 ± 11 mins

Excited to share my outcomes <a href="/CRT_meeting/">CRT Meeting</a> on 4D ICE-guided LAAC <a href="/SiemensHealth/">Siemens Healthineers</a> <a href="/BSCCardiology/">BostonSci Cardiology</a>. 
72 consecutive all comers pt:
🔹️Procedure is safe and feasible
🔹️97% successful LAAC 
🔹️97% cessation of AC @ 45 days
🔹️All dc ~ 24 hrs
🔹️Average procedure time 47 ± 11 mins
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

Here’s my guide to navigate the #ACC25 trials, coming this weekend and featured in many journals with a (very) high impact factor. 1. WARRIOR = Intensive medical therapy in women with ANOCA/INOCA 2. STRIDE = Semaglutide in type 2 diabetes and peripheral artery disease 3. API-CAT

Here’s my guide to navigate the #ACC25 trials, coming this weekend and featured in many journals with a (very) high impact factor.

1. WARRIOR = Intensive medical therapy in women with ANOCA/INOCA
2. STRIDE = Semaglutide in type 2 diabetes and peripheral artery disease
3. API-CAT
MyJSCAI (@myjscai) 's Twitter Profile Photo

🫀 SCAI experts Andrew M. Goldsweig, MD, MS Ivan Hanson William W. O'Neill Srihari S. Naidu, MD Babar Basir break down the Recover III study💡findings reveal pts improving w/in 24hrs are responders, while those who remain in Stage E face different challenges. 📺Tune in now: ow.ly/3IbW50VvSfA

🫀 <a href="/SCAI/">SCAI</a> experts <a href="/AGoldsweig/">Andrew M. Goldsweig, MD, MS</a> <a href="/IvanHansonMD/">Ivan Hanson</a> <a href="/BillONeillMD/">William W. O'Neill</a> <a href="/SrihariNaiduMD/">Srihari S. Naidu, MD</a> <a href="/Babar_Basir/">Babar Basir</a> break down the Recover III study💡findings reveal pts improving w/in 24hrs are responders, while those who remain in Stage E face different challenges.

📺Tune in now: ow.ly/3IbW50VvSfA